Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.470
-0.020 (-0.45%)
Nov 4, 2024, 4:00 PM EST - Market closed
Tenax Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -12.57 | -7.71 | -11.05 | -32.47 | -9.85 | -8.39 | |
Depreciation & Amortization | 0.01 | 0.01 | 0.11 | 0.11 | 0.11 | 0.11 | |
Loss (Gain) From Sale of Assets | - | 0 | -0 | - | - | 0 | |
Loss (Gain) From Sale of Investments | - | - | - | 0.01 | 0.01 | -0 | |
Stock-Based Compensation | 0.21 | 0.19 | 0.37 | 0.77 | 0.35 | 0.27 | |
Other Operating Activities | 0.03 | 0.02 | 0 | 21.34 | 0 | - | |
Change in Accounts Receivable | -0.09 | -0.31 | -0.36 | -0.02 | 0.7 | -0.32 | |
Change in Accounts Payable | 0.96 | 1.89 | -0.34 | -0.54 | -0.54 | 0.88 | |
Change in Other Net Operating Assets | - | - | -0.12 | -0.04 | -0.06 | -0.1 | |
Operating Cash Flow | -11.45 | -5.9 | -11.39 | -10.86 | -9.27 | -7.56 | |
Capital Expenditures | - | - | -0 | -0.01 | -0 | -0 | |
Sale of Property, Plant & Equipment | - | 0 | - | - | - | - | |
Investment in Securities | - | - | - | 0.46 | 0.02 | 0 | |
Investing Cash Flow | - | 0 | -0 | 0.45 | 0.02 | -0 | |
Long-Term Debt Issued | - | - | - | - | 0.24 | - | |
Total Debt Issued | - | - | - | - | 0.24 | - | |
Short-Term Debt Repaid | - | -0.62 | - | - | - | - | |
Total Debt Repaid | -0.57 | -0.62 | - | - | - | - | |
Net Debt Issued (Repaid) | -0.57 | -0.62 | - | - | 0.24 | - | |
Issuance of Common Stock | - | 0 | 0 | 0.54 | 10.35 | 0.1 | |
Other Financing Activities | 14.13 | 14.19 | 7.93 | 9.19 | - | - | |
Financing Cash Flow | 7.44 | 13.57 | 7.93 | 9.74 | 10.6 | 0.1 | |
Net Cash Flow | -4.01 | 7.67 | -3.46 | -0.67 | 1.34 | -7.46 | |
Free Cash Flow | -11.45 | -5.9 | -11.39 | -10.86 | -9.28 | -7.56 | |
Free Cash Flow Per Share | -12.14 | -23.76 | -619.37 | -844.53 | - | - | |
Levered Free Cash Flow | -7.55 | -3.79 | -7.77 | -19.33 | -5.49 | -4.44 | |
Unlevered Free Cash Flow | -7.53 | -3.77 | -7.76 | -19.33 | -5.49 | -4.44 | |
Change in Net Working Capital | -0.4 | -1.17 | 1.33 | 0.5 | -0.22 | -0.53 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.